STRYKER CORP Payments for (Proceeds from) Short-term Investments
STRYKER CORP (SYK) reported Payments for (Proceeds from) Short-term Investments of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromShortTermInvestments · last filed 2026-07-31
- STRYKER CORP payments for (proceeds from) short-term investments for the quarter ending 2026-06-30 was $0.00.
- STRYKER CORP payments for (proceeds from) short-term investments for the quarter ending 2026-03-31 was $0.00.
- STRYKER CORP payments for (proceeds from) short-term investments for the quarter ending 2025-12-31 was $0.00.
- STRYKER CORP payments for (proceeds from) short-term investments for the quarter ending 2025-09-30 was $0.00.
- STRYKER CORP payments for (proceeds from) short-term investments for fiscal 2025 was -$750.00M, a 200.00% decline from fiscal 2024.
- STRYKER CORP payments for (proceeds from) short-term investments for fiscal 2024 was $750.00M.
- STRYKER CORP payments for (proceeds from) short-term investments for fiscal 2023 was $0.00.
| Period end | Payments for (Proceeds from) Short-term Investments 3 month | Payments for (Proceeds from) Short-term Investments 6 month | Payments for (Proceeds from) Short-term Investments 9 month | Payments for (Proceeds from) Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $0.00 10-Q · filed 2026-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-07-31 | $0.00 derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | $0.00 derived: sum of 3 quarters · filed 2026-07-31 | -$750.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $0.00 derived: sum of 2 quarters · filed 2026-07-31 | -$750.00M 10-Q · filed 2025-10-31 | -$750.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$750.00M 10-Q · filed 2026-07-31 | -$750.00M derived: sum of 3 quarters · filed 2026-07-31 | |
| 2025-03-31 | -$750.00M 10-Q · filed 2026-05-11 | -$750.00M derived: sum of 2 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $750.00M 10-K · filed 2026-02-11 | ||
| 2024-09-30 | $750.00M 10-Q · filed 2025-10-31 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |